SQLite Web: event_store.db

Update row 128193 in events

seq

Primary key. INTEGER

id

TEXT NOT NULL

kind

TEXT NOT NULL

ts

TEXT NOT NULL

actor

TEXT

subject_entity_ids

TEXT

payload

{"created_at":"2026-04-18T03:05:05.644967+00:00","dedupe_key":"signal_enriched:discovery_sec_filing_delta:b419ee9f889f4bdd","evidence_event_ids":["evt_a4af2c737339"],"signal_type":"discovery_sec_filing_delta","source":"discovery_sec_filings","value":{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/875320/0000875320-26-000161.txt","as_of":"2026-04-18T03:05:05.644967+00:00","canonical_url":"https://www.sec.gov/Archives/edgar/data/875320/0000875320-26-000161.txt","company":"VERTEX PHARMACEUTICALS INC / MA","enrichment":{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/875320/0000875320-26-000161.txt","article_chars":1701,"article_truncated":false,"blocked_reason":null,"candidate_id":"sc_434a224248b2266e","canonical_host":"sec.gov","canonical_is_aggregator":false,"canonical_url":"https://www.sec.gov/Archives/edgar/data/875320/0000875320-26-000161.txt","content_type":"text/plain","enriched_at":"2026-04-18T03:19:23.716531+00:00","extraction_method":"trafilatura","fetched_description":"","fetched_title":"","final_url":"https://www.sec.gov/Archives/edgar/data/875320/0000875320-26-000161.txt","html_truncated":false,"paywall_likely":false,"publisher_domain":"sec.gov","publisher_resolution":"canonical_url","requested_url":"https://www.sec.gov/Archives/edgar/data/875320/0000875320-26-000161.txt","source_event_id":"evt_a4af2c737339","source_quality":"medium","status_code":200,"version":"signal_enrichment_v2"},"form_type":"4","fp":"378c3ada1a5baafe","kind":"sec_filing","published_at":"20260417","publisher_domain":"sec.gov","signal_understanding":{"analysis_basis":"article","claim_confidence":0.62,"dates_mentioned":["2026-04-17","2026-04-15","2026-04-17T03:05:05.644967+00:00"],"entities":[{"asset_class":"equity","name":"VERTEX PHARMACEUTICALS INC / MA","relevance":"high","symbol":"VRTX","type":"issuer"},{"asset_class":"person","name":"SACHS BRUCE I","relevance":"high","symbol":"","type":"reporting_owner"},{"asset_class":"equity","name":"Common Stock","relevance":"high","symbol":"","type":"security"}],"event_type":"listing","information_gaps":["What specifically changed vs prior known state is not provided in the signal (no prior Form 4 state or comparison data included).","The provided text does not clearly label which numeric values (107.345, 442.50, 15671.866) correspond to which Form 4 fields (e.g., number of units, transaction price, total value).","No explicit transaction type (e.g., grant, vesting, acquisition) is stated beyond the presence of \u201cDeferred Stock Units.\u201d","No guidance or financial implications for the company are explicitly disclosed in the provided text."],"key_facts":["SEC accession number: 0000875320-26-000161.","Form type: 4 (Form 4).","Conformed period of report: 20260415; filed as of date: 20260417.","Reporting owner: Bruce I. Sachs (CENTRAL INDEX KEY: 0001197036).","The filing includes \u201cDeferred Stock Units\u201d with a date shown as 2026-04-15.","The filing states: \u201cEach deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Sachs' service on our board of directors, (ii) a change of control of our company and (iii) Mr. Sachs' disability or death.\u201d","A price/amount line appears in the text: \u201c107.345\u201d and \u201c442.50\u201d and \u201c107.345 15671.866 D\u201d (exact mapping to fields is not explicitly labeled in the provided text)."],"numeric_claims":[{"label":"Price shown","value":"107.345"},{"label":"Amount shown","value":"442.50"},{"label":"Quantity shown","value":"15671.866"}],"primary_claim":"A Form 4 was filed by Vertex Pharmaceuticals (VRTX) on 2026-04-17 for reporting-owner Bruce I. Sachs, including deferred stock units tied to common stock.","relevance_score":0.45,"sentiment":"neutral","source_quality":"medium","summary":"Vertex Pharmaceuticals (VRTX) filed a Form 4 on 2026-04-17 covering a transaction related to deferred stock units held by Bruce I. Sachs. The filing states each deferred stock unit represents one share of common stock and is paid out in common stock upon specified triggering events.","topics":["SEC Form 4","insider/deferred stock units","common stock payout mechanics"]},"source":"sec_edgar","source_domain":"sec.gov","summary":"Form 4 \u00b7 VERTEX PHARMACEUTICALS INC / MA \u00b7 Filed 20260417","ticker":"VRTX","tickers":["VRTX"],"title":"VRTX filed 4","url":"https://www.sec.gov/Archives/edgar/data/875320/0000875320-26-000161.txt"}}

TEXT NOT NULL

source_ref

TEXT

confidence

REAL (default 0.0

dedupe_key

TEXT

episode_id

TEXT

created_at

TEXT NOT NULL (default strftime('%Y-%m-%dT%H:%M:%fZ','now')

Cancel